Mother Science

New to our radar, not newly founded. A recognisable ingredient platform can make a small assortment easier to understand, but it concentrates the evidence burden: the strategic asset is the product experience, evidence and commercial rights together—not the molecule name alone. The reported March 2026 Sephora rollout is useful background; repeat rates, retail reorders and ingredient-to-product evidence remain undisclosed.